Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
UBS
Federal Trade Commission
US Department of Justice
McKesson

Generated: March 18, 2019

DrugPatentWatch Database Preview

Us Worldmeds Llc Company Profile

« Back to Dashboard

What is the competitive landscape for US WORLDMEDS LLC, and when can generic versions of US WORLDMEDS LLC drugs launch?

US WORLDMEDS LLC has four approved drugs.

There are three US patents protecting US WORLDMEDS LLC drugs.

There are seventy-six patent family members on US WORLDMEDS LLC drugs in thirty-one countries and eight supplementary protection certificates in seven countries.

Summary for Us Worldmeds Llc
International Patents:76
US Patents:3
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Us Worldmeds Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Us Worldmeds Llc XADAGO safinamide mesylate TABLET;ORAL 207145-002 Mar 21, 2017 RX Yes Yes 8,278,485 ➤ Try a Free Trial Y ➤ Try a Free Trial
Us Worldmeds Llc XADAGO safinamide mesylate TABLET;ORAL 207145-001 Mar 21, 2017 RX Yes No 8,278,485 ➤ Try a Free Trial Y ➤ Try a Free Trial
Us Worldmeds Llc ZELNORM tegaserod maleate TABLET;ORAL 021200-002 Jul 24, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Us Worldmeds Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-003 Approved Prior to Jan 1, 1982 3,982,021 ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 3,935,267 ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 3,935,267 ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 3,982,021 ➤ Try a Free Trial
Us Worldmeds Llc ZELNORM tegaserod maleate TABLET;ORAL 021200-002 Jul 24, 2002 5,510,353 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Us Worldmeds Llc Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1613296 241 50017-2015 Slovakia ➤ Try a Free Trial PRODUCT NAME: SAFINAMID; REGISTRATION NO/DATE: EU/1/14/984/001 - EU/1/14/984/010 20150226
0505322 C00505322/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: TEGASEROD; REGISTRATION NO/DATE:IKS 55689 20011030
1613296 CR 2015 00042 Denmark ➤ Try a Free Trial PRODUCT NAME: KOMBINATION AF SAFINAMID, HERUNDER SAFINAMID METHANSULFONAT, OG LEVODOPA/PDI; REG. NO/DATE: EU/1/14/984/001-010 20150226
1613296 300752 Netherlands ➤ Try a Free Trial PRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
1613296 15C0054 France ➤ Try a Free Trial PRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Express Scripts
AstraZeneca
Queensland Health
US Department of Justice
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.